205 related articles for article (PubMed ID: 1582589)
21. 31-43 amino acid sequence of the alpha-gliadin induces anti-endomysial antibody production during in vitro challenge.
Picarelli A; Di Tola M; Sabbatella L; Anania MC; Di Cello T; Greco R; Silano M; De Vincenzi M
Scand J Gastroenterol; 1999 Nov; 34(11):1099-102. PubMed ID: 10582760
[TBL] [Abstract][Full Text] [Related]
22. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
Pizzuti D; Buda A; D'Odorico A; D'Incà R; Chiarelli S; Curioni A; Martines D
Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
[TBL] [Abstract][Full Text] [Related]
23. Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease.
Scott H; Sollid LM; Fausa O; Brandtzaeg P; Thorsby E
Scand J Immunol; 1987 Nov; 26(5):563-71. PubMed ID: 3500504
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study.
Ciacci C; Maiuri L; Russo I; Tortora R; Bucci C; Cappello C; Santonicola A; Luciani A; Passananti V; Iovino P
Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1170-6. PubMed ID: 19473192
[TBL] [Abstract][Full Text] [Related]
25. Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.
Salvati VM; Mazzarella G; Gianfrani C; Levings MK; Stefanile R; De Giulio B; Iaquinto G; Giardullo N; Auricchio S; Roncarolo MG; Troncone R
Gut; 2005 Jan; 54(1):46-53. PubMed ID: 15591503
[TBL] [Abstract][Full Text] [Related]
26. Local challenge of oral mucosa with gliadin in patients with coeliac disease.
Lähteenoja H; Mäki M; Viander M; Toivanen A; Syrjänen S
Clin Exp Immunol; 2000 Apr; 120(1):38-45. PubMed ID: 10759761
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin production by coeliac biopsies in organ culture.
Wood GM; Shires S; Howdle PD; Losowsky MS
Gut; 1986 Oct; 27(10):1151-60. PubMed ID: 3781327
[TBL] [Abstract][Full Text] [Related]
28. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study.
Catassi C; Rossini M; Rätsch IM; Bearzi I; Santinelli A; Castagnani R; Pisani E; Coppa GV; Giorgi PL
Gut; 1993 Nov; 34(11):1515-9. PubMed ID: 8244135
[TBL] [Abstract][Full Text] [Related]
29. Intestinal antibody pattern of coeliac disease: association with gamma/delta T cell receptor expression by intraepithelial lymphocytes, and other indices of potential coeliac disease.
Arranz E; Bode J; Kingstone K; Ferguson A
Gut; 1994 Apr; 35(4):476-82. PubMed ID: 8174984
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells.
Holm K; Savilahti E; Koskimies S; Lipsanen V; Mäki M
Gut; 1994 Jan; 35(1):55-60. PubMed ID: 8307450
[TBL] [Abstract][Full Text] [Related]
31. Effects of gliadin-derived peptides from bread and durum wheats on small intestine cultures from rat fetus and coeliac children.
Auricchio S; De Ritis G; De Vincenzi M; Occorsio P; Silano V
Pediatr Res; 1982 Dec; 16(12):1004-10. PubMed ID: 7155669
[TBL] [Abstract][Full Text] [Related]
32. Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease.
Barone MV; Gimigliano A; Castoria G; Paolella G; Maurano F; Paparo F; Maglio M; Mineo A; Miele E; Nanayakkara M; Troncone R; Auricchio S
Gut; 2007 Apr; 56(4):480-8. PubMed ID: 16891357
[TBL] [Abstract][Full Text] [Related]
33. In vitro proliferation of lymphocytes from celiac children and their first-degree relatives in response to wheat gliadin-derived peptides.
Auricchio S; Buffolano W; Ciccimarra F; De Vincenzi M; Silano V; Zapponi G
J Pediatr Gastroenterol Nutr; 1982; 1(4):515-24. PubMed ID: 7186066
[TBL] [Abstract][Full Text] [Related]
34. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
Scand J Immunol; 1997 Jul; 46(1):103-8. PubMed ID: 9246215
[TBL] [Abstract][Full Text] [Related]
35. In vivo gluten ingestion in coeliac disease.
Ciclitira PJ; Ellis HJ
Dig Dis; 1998; 16(6):337-40. PubMed ID: 10207218
[TBL] [Abstract][Full Text] [Related]
36. A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation?
Biagi F; Ellis HJ; Parnell ND; Shidrawi RG; Thomas PD; O'Reilly N; Corazza GR; Ciclitira PJ
Aliment Pharmacol Ther; 1999 Jul; 13(7):945-50. PubMed ID: 10383530
[TBL] [Abstract][Full Text] [Related]
37. Expression of the common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease.
Trejdosiewicz LK; Malizia G; Oakes J; Losowsky MS; Janossy G
J Clin Pathol; 1985 Sep; 38(9):1002-6. PubMed ID: 2931454
[TBL] [Abstract][Full Text] [Related]
38. In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours.
Jos J; Lenoir G; Ritis G D; Rey J
Scand J Gastroenterol; 1975; 10(2):121-8. PubMed ID: 1091964
[TBL] [Abstract][Full Text] [Related]
39. An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture.
Falchuk ZM; Gebhard RL; Sessoms C; Strober W
J Clin Invest; 1974 Feb; 53(2):487-500. PubMed ID: 11344562
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of HLA-D gene products in the normal and coeliac small bowel.
Kelly J; Weir DG; Feighery C
Tissue Antigens; 1988 Mar; 31(3):151-60. PubMed ID: 3376099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
